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Abstract
Background: Events before birth, condition at birth, events immediately following birth, and
condition in early childhood are linked together, and have implications for health and disease in
adulthood. At present, there is lack of clarity about the tests that purport to link these various
stages. This is partly because there is paucity of collated information about the best strategies for
predicting longer-term outcomes before (using tests in fetal period) or after birth (using tests in
neonatal period, infancy as well as early childhood).
Methods/Design:  A series of systematic reviews and meta-analyses will be undertaken to
determine, amongst neonates, the ability of various tests and measures to predict infant, childhood
and adult outcomes. We will search Medline, Embase, Cochrane Library, MEDION, citation lists of
review articles and eligible primary articles and will contact experts in the field. Independent
reviewers will select studies, extract data and assess study quality according to established criteria.
Language restrictions will not be applied. Data synthesis will involve meta-analysis (where
appropriate), exploration of heterogeneity and publication bias. Evidence collated will be graded for
its quality to support decision making.
Discussion: The project will collate, synthesise and evaluate the available evidence concerning the
value of tests of neonatal wellbeing to predict long term outcomes. The systematic reviews will
assess the quality of available evidence and identify tests with the strongest association with
outcomes, and assess their economic value. The output of this project will help formulate practice
recommendations.
Background
Events before birth, condition at birth, events immedi-
ately following birth, and condition in early childhood
are linked together, and may have implications for health
and disease in adulthood [1]. A variety of parameters are
used to assess neonatal wellbeing such as the APGAR
score,[2] umbilical cord pH, [3] need for neonatal inten-
sive care and growth measurements including birth
weight, head circumference and skin fold thickness [4].
Studies of tests or interventions in pregnancy and labour
often use these factors as outcome measures [5]. Similarly,
complications in childhood such as cerebral palsy may be
attributed to antenatal or intrapartum events where there
is an abnormal neonatal test such as low cord pH or low
birth weight. However, there are conflicting results in
existing studies regarding the strength of association
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between an abnormal neonatal test and adverse out-
comes. A comprehensive systematic review of the litera-
ture on all available tests can improve our ability to
identify those infants at greatest risk of developing imme-
diate, childhood and adult complications.
Let us for example, take umbilical cord pH at birth,
defined as the pH and base excess in arterial and venous
samples, measured from a segment of umbilical cord
which is double clamped immediately after delivery. It is
widely used as an objective measure of perinatal asphyxia,
a major cause of neonatal and childhood morbidity and
mortality worldwide. Acidaemia at birth has been associ-
ated with neonatal complications such as hypoxic ischae-
mic encephalopathy and seizures, [6] liver
dysfunction,[7] acute renal impairment,[8] death,[9] and
long term morbidity such as cerebral palsy and develop-
mental delay [10]. Pathological fetal acidosis is consid-
ered to occur at an arterial cord pH of <7.00 and a base
deficit ≥ 12 mmol/l, levels to which cerebral palsy is often
attributed [10]. The criteria have been derived through
consensus statement rather than through evaluation of
collated evidence summaries in this field [11,12]. Existing
studies of the association between pH levels and out-
comes have drawn inconsistent inferences. This discrep-
ancy may be due to the different parameters measured
(arterial or venous pH and base excess), the different
thresholds used to define abnormality, and the variety of
outcomes evaluated. This and other inconsistencies in the
literature on neonatal testing will be explored in our
review.
The APGAR score, too, has been widely used for many
years to quantify the neonatal condition at birth, consid-
ering heart rate, respiratory effort, colour and tone at 1, 5
and 9 minutes of age. Although it provides a useful sum-
mary of an infant's condition, studies correlating it to long
term outcomes have varied widely in their findings [4,13].
The significance of a low APGAR score where the clinical
condition improves quickly is therefore uncertain, and
will be investigated within the scope of this project. Simi-
larly, measures at birth for fetal growth restriction have
been associated with neonatal mortality,[14] childhood
disability and impaired neurodevelopment,[15,16] edu-
cational disadvantage and disease in adult life (e.g. diabe-
tes mellitus, hypertension) [17,18]. However, a variety of
different reference criteria for confirmation of growth
restriction are used, including absolute birth weight
<2500 g, birth weight < 10th centile adjusted for gesta-
tional age and local population values, and neonatal pon-
deral index < 10th centile [19]. There is lack of consensus
as to which of these reference standards and thresholds
has the strongest correlation with adverse outcome. This
review will consider each parameter in turn and assess the
association of neonatal, childhood and adult outcomes
with each.
The need for admission to neonatal intensive care (NICU)
is widely used as a reference standard for overall neonatal
morbidity. However, the policy for admitting neonates
varies widely between intensive care units both nationally
and internationally, for example some would admit all
babies born to diabetic mothers for a period of observa-
tion [20]. This variation may affect the association of
NICU admission with long term outcomes. More specific
assessment of initial neonatal morbidity involves scoring
systems used in the intensive care setting such as the Clin-
ical Risk Index for Babies (CRIB) and the Score for Neona-
tal Acute Physiology (SNAP). We will assess the
correlation between these scores and short and long term
outcomes.
Clarification of the correlation between neonatal tests and
subsequent outcomes is necessary to optimise clinical
decision making and counselling of parents when an
infant is affected. In turn, a better understanding of the
long term associations of neonatal tests will improve
understanding of the implications of tests and interven-
tions in pregnancy that affect neonatal outcomes.
Methods/Design
Funded by the Mary Crosse Fund at Birmingham
Women's Hospital a systematic review project based on
this protocol will be conducted.
In 1973 Dr Crosse bequeathed the legacy of her estate to
the former South Birmingham Hospital Management
Committee for the development of research in Maternity,
Neonatal and Special Care Baby Unit.
Objectives
To determine the association and clinical impact of neo-
natal findings and tests (including birth weight, Apgar
scores and umbilical cord pH) with morbidity and mor-
tality in infancy, childhood and adulthood, using system-
atic reviews and meta-analyses.
Search Strategy
Literature will be identified using:
• General bibliographic databases including
MEDLINE (PubMED) and EMBASE (OVID)
￿ Specialist electronic databases: the Cochrane Library
(DARE, CCTR), MEDION
￿ Contact with individual experts and those with an
interest in this field to uncover grey literatureBMC Pregnancy and Childbirth 2009, 9:49 http://www.biomedcentral.com/1471-2393/9/49
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￿ Hand- searching of selected specialist journals
￿ Checking of reference lists of relevant review articles
and papers that will be eligible for inclusion
Searches will we performed to identify the neonatal tests
in question and combined with a search to identify mor-
bidity and mortality. The comprehensive search strategy
will aim to find all primary studies reporting the associa-
tion of each neonatal test with any measure of childhood
or adult morbidity and mortality. The search strategy for
umbilical cord pH may be viewed as an additional file 1
(other searches are available for authors on request).
Search terms related to the test (e.g. Umbilical cord,
Hydrogen-ion concentration, Asphyxia neonatorum,
umbilical artery pH, cord pH) are combined using 'and'
with MESH headings (e.g. Human development, Infant
mortality) and keywords (e.g. developmental delay,
handicap) to encompass neonatal mortality and short
and long term morbidity. The search will be restricted to
human studies only. No language restrictions will be
applied. All databases will be searched from inception
and updated at 6 monthly intervals. A comprehensive
database of the literature will be constructed (Reference
Manager 11.0) to allow us to handle citations efficiently
[21].
Inclusion Criteria
Studies will be selected for inclusion in the reviews using
the selection criteria based on population, index test, ref-
erence standard and study design of interest.
Population
Neonates in any health care setting
Tests
neonatal tests will be prioritised on the basis of clinical
relevance after consultation with experts in the field (fig-
ure 1).
Outcome measure
Any measure of infant, childhood or adult morbidity or
mortality, (figure 1).
Study design
Observational studies (cohorts, case-control) allowing
generation of 2 × 2 tables of the association between neo-
natal test and outcome measure. Case series ≤ 5 will be
excluded due to the likely association with bias and
imprecision.
Study selection process
Studies will be selected for inclusion in the review in a two
stage process using the selection criteria detailed above.
Firstly, the titles and abstracts of the citations in the Refer-
ence Manager database will be assessed by one reviewer.
All papers felt to be relevant will be obtained in full text
version. Two independent reviewers will then select the
studies which meet predefined criteria, defined prior to
commencement and individualised for each review. Disa-
greements will be resolved by consensus or input from a
third reviewer.
Data Extraction
A data extraction form will be designed for each review;
variations between reviews will mainly be on the informa-
tion extracted regarding the index test. Data will be
extracted on: identification of study (first author, year of
publication, country of investigation, language of paper);
population (health care setting, number of participating
centres, level of risk assigned by author and clinical data
on risk factors, inclusion period); study design (design,
data collection, enrolment, completeness of follow up);
index test (gestation, method of performing test, intra and
inter-observer variation, cut off level); reference standard
(incidence, reference standard used, cut off level, total
number of individuals analysed for results); results (nec-
essary data for construction of 2 × 2 table, all results will
be collected for reported index tests at any cut-off level,
any measure of statistical accuracy reported).
The data extraction will be conducted in duplicate using
the pre-designed form. Disagreements between reviewers
will again be resolved by consensus or arbitration. Where
multiple publications are identified, only the most recent
and/or complete study will be included. Data will be
entered onto an Excel spreadsheet.
Study quality assessment
Study and reporting quality will be assessed by at least one
reviewer for all included manuscripts. Methodologic qual-
ity is a construct defined as the confidence that the study
design, conduct and analysis minimises bias[22] in the
estimation of the association between test and outcome,
thereby maintaining internal validity (i.e. the degree to
which the results of this observation are correct for the
patients being studied). Another construct is that it is a set
of parameters in the design and conduct of a study that
reflects the validity of the outcome, related to the external
and internal validity and the statistical model used [23].
For our review these parameters will be developed adapt-
ing the QUADAS tool [24]. Elements of study design
which may have a direct relationship to bias and variation
in a test accuracy study will be assessed with elements of
the STARD checklist [25]. We have used such tools in our
previous work [26].
In the assessment of study quality, prospective recruit-
ment of patients with a consecutive or random recruit-
ment pattern will be considered ideal. Sufficient clinicalBMC Pregnancy and Childbirth 2009, 9:49 http://www.biomedcentral.com/1471-2393/9/49
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Flow diagram to illustrate neonatal tests and outcomes to be examined in systematic reviews Figure 1
Flow diagram to illustrate neonatal tests and outcomes to be examined in systematic reviews.
Neonatal tests 
Skin fold thickness 
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Mid-arm circumference/head 
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Abnormal cord pH at birth 
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information should be given to assign a level of risk of
complications, which ideally should be stated by the
authors. The quality of performance and reporting of the
index test will be assessed to look at elements of the test
that may introduce bias. Information regarding the refer-
ence standard including method of determination, execu-
tion and blinding will be extracted. Ideal study design will
be cohort studies; case control study design has been
shown to affect accuracy and where numbers of studies
permit these will be excluded from meta-analysis [27].
Verification bias will be assessed using a flow diagram to
assess the number of eligible individuals completing both
index test and outcome measure, and those excluded from
the analysis with reasons. With ideal verification studies
will account for all eligible individuals, state how indeter-
minate results were handled, and > 90% of those under-
going the index test should progress to complete the
outcome measure. Where possible an individual quality
assessment will be tailored to each review, using the most
important items from validated tools. The assessment of
quality will be represented by a stacked bar chart.
We will use the GRADE approach to determine whether
we could recommend the use of each test in a clinical con-
text. This approach is transparent in its considerations
[28]. This considers the quality of the evidence not only
according to the test accuracy, but the impact of the test on
patient-important outcomes and takes into account fac-
tors influencing the quality of the evidence such as the
study design, potential sources of bias and the precision of
the results [29].
Data description
For each test, information on individual studies will be
summarised as follows:
￿ Table with methodological and reporting charac-
teristics of included studies
The table will state the number of women in each
study, the incidence of each adverse outcome (based
on the number of analysed cases divided by the total
number of individuals at baseline).
￿ Summary of quality and reporting items of the
included studies
Results will be presented as 100% stacked bars, where
the bars represent a quality item and the figures in the
stacks represent the number of studies
￿ Forest plots of odds ratios and 95% CIs
Odds ratios, analysed as (true positive/false positive)/
(false negative/true negative) will be presented.
￿ Table with subgroup analyses (if applicable)
￿ Grade tables
For each test the tables will state the number of stud-
ies, design, limitations, test results with outcomes
important to patients, the indirectness of the impact of
the test result on patient-important outcomes, the pre-
cision of the data, publication bias and an assessment
of the overall quality of the evidence.
Statistical Analyses
From the 2 × 2 tables, odds ratios will be calculated for
each study along with their 95% confidence intervals
(CIs) [30]. When 2 × 2 tables contain zero cells, 0.5 will
be added to each cell to enable calculations [31]. In each
review, results will be visualised using Forest plots and
ROC plots; extreme values, outliers and threshold phe-
nomena will be explored.
Results will be analysed in groups according to the index
test performed and the outcome measure studied, these
will be defined a priori for each review. Meta-analysis will
be used when appropriate. Pooled summary estimates
will be produced in the form of odds ratios, as these are
often relatively constant regardless of the diagnostic
threshold and are frequently used to demonstrate a causal
association in epidemiological studies [32]. The range of
uncertainty will be calculated using the 95% confidence
intervals of the odds ratios for each test. A fixed or random
effects model will be used as appropriate depending on
the degree of heterogeneity present.
Heterogeneity of results between studies will be assessed
graphically by inspection of forest plots and ROC plots.
The X2 and inconsistency squared will be used as statistical
measures of heterogeneity. Where heterogeneity is not
present (X2 >0.10, p < 0.05 and I2 < 50%) the fixed effect
pooling method will be used and where relevant we will
consider the use of the bivariate meta-regression model
[22,33]. Where heterogeneity is present, this will be
explored using meta-regression analyses. Factors consid-
ered to be important beforehand will be used for the anal-
ysis, including:
￿ Variations in population, high and low risk depend-
ing antenatal or intrapartum factors
￿ Study quality
￿ Study design: Prospective vs. Retrospective data col-
lection
￿ Variations in the type of index test and outcome
measure and the thresholds usedBMC Pregnancy and Childbirth 2009, 9:49 http://www.biomedcentral.com/1471-2393/9/49
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Analysis for the assessing the risk of publication bias will
be carried out by producing funnel plots of accuracy esti-
mates against corresponding variances [28]. When no
publication bias is suspected the plots will be symmetrical
and funnel shaped because smaller studies are expected to
have increased variation in estimates of accuracy.
When interpreting the data we will consider the criteria
proposed by Hill to establish causality [34]. The consist-
ency of the results, the biological plausibility of the find-
ings and the specificity and temporality of the
associations demonstrated will be examined.
Data syntheses will be performed using meta-disc version
1.4, STATA version 10.0 and StatsDirect version 2.7.2.
Discussion
This project will comply with guidelines on conducting
systematic reviews of diagnostic tests. The methodology of
diagnostic systematic reviews is rapidly evolving with a
focus on assessing the effect of study design and quality
on accuracy.
This project will utilise all recent developments in the
methodology and statistical analysis of systematic
reviews. This will include bivariate meta-analysis, a tech-
nique which analyses sensitivity and specificity jointly,
accounting for the presence of a threshold effect and cor-
relation between the two measures. We will also utilise
guidelines on the methodology of systematic reviews to
assess causation. The results of the review will help pro-
duce a set of neonatal tests to predict neonatal, childhood
and adult morbidity and mortality, which can be used to
inform clinical management of these individuals. The
recently recommended GRADE approach to rating the
quality of evidence and the strength of the recommenda-
tions made on the results will comprehensively explain
the findings of our reviews and the rationale behind our
recommendations to enable the confident use of our
results to influence current practice and recommend fur-
ther research.
The anticipated problems in this project include the vari-
ety of outcome measures purported to be associated with
long term outcomes and the likely variety of definitions
and thresholds for these outcomes. This will provide chal-
lenges to searching, and the search strategies employed
will necessarily be broad, leading to a large database of
potential studies to be examined. The heterogeneous
nature of the outcomes may limit meta-analysis. In order
to combat this problem we will perform meta-analysis
according to pre-defined clinically relevant groups of out-
come measures and we will explore any remaining heter-
ogeneity with meta-regression. Our ability to establish
causality may be limited by the reporting in the primary
studies, for example assessment of dose-response relation-
ships are dependent on the reporting of multiple thresh-
olds; if the primary studies report a single cut-off then the
dose-response curve would be difficult to explore. Like-
wise the specificity of the outcomes in relation to the test
examined relies on the primary studies reporting other
possible causative factors, such as the gestation at birth
when examining the relationship or umbilical cord pH
with cerebral palsy, as both may influence the outcome
and therefore confound the results. In grading the evi-
dence the main challenges are likely to arise from the lack
of direct evidence of the impact of the test on patient out-
comes. For example, there is a lack of proven interven-
tions to improve long term outcomes in individuals with
an abnormal test at birth. We will therefore have to infer
benefit based on increased certainty to the patient of a
normal or abnormal outcome, which will inevitably
weaken the strength of our recommendations. However,
areas where there is a paucity of data can be identified and
used to guide future primary research. Results will be pub-
lished through 2009-2011.
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